Article
Tumor patterns and cancer risk in carriers of TP53 exonic germline variants that alter mRNA splicing.
European journal of human genetics : EJHG - 1 Aug 2026
Schönegger Deborah, Montellier Emilie, Blanchet Sandrine, Freycon Claire, Monti Paola, Goudie Catherine, Bougeard Gaëlle, Kratz Christian P, Hainaut Pierre, Reymer Anna
Abstract excerpt
Abnormal RNA splicing is an underrecognized driver of pathogenicity in germline TP53 - the cause of Li-Fraumeni syndrome (LFS). We re-evaluated exonic single-nucleotide variants (SNVs) that yield missense or synonymous changes for spliceogenic effects by integrating SpliceAI prediction, in-vitro minigene assays, and analysis of tumor RNA-seq from TCGA, and assessed genotype-phenotype correlations using clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
